Literature DB >> 9919324

Age at onset in geriatric bipolar disorder. Effects on clinical presentation and treatment outcomes in an inpatient sample.

M E Wylie1, B H Mulsant, B G Pollock, R A Sweet, G S Zubenko, A E Begley, M Gregor, E Frank, C F Reynolds, D J Kupfer.   

Abstract

The authors report on 62 inpatients over age 60 who met DSM-III-R criteria for bipolar disorder, divided into early- and late-onset groups by their median age at lifetime onset, 49 years, in order to examine differences in demographic and clinical characteristics, treatment parameters, and outcome in the two groups during a short-term hospitalization. The late-onset group was more likely to have psychotic features and to demonstrate cerebrovascular risk/burden. However, both groups had similar and highly significant improvements in the Brief Psychiatric Rating Scale, Global Assessment Scale, and the Mini-Mental State Exam, and 87% were able to be discharged to settings no more restrictive than those at admission.

Entities:  

Mesh:

Year:  1999        PMID: 9919324

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  16 in total

1.  Associations between illness duration and health-related quality of life in specified mental and physical chronic health conditions: results from a population-based survey.

Authors:  Lucy Busija; Jeretine Tan; Kerrie M Sanders
Journal:  Qual Life Res       Date:  2017-05-12       Impact factor: 4.147

Review 2.  [Bipolar affective disorders in senescence].

Authors:  Jens Benninghoff; Peter Brieger
Journal:  Z Gerontol Geriatr       Date:  2018-09-28       Impact factor: 1.281

3.  Late-life Onset Mania After Varenicline Use: A Case Report.

Authors:  Abdullah Akpinar; Gülin Özdamar Ünal; İnci Meltem Atay; Duru Gündoğar; Ramazan Özçankaya
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

4.  Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD.

Authors:  Robert C Young; Herbert C Schulberg; Ariel G Gildengers; Martha Sajatovic; Benoit H Mulsant; Laszlo Gyulai; John Beyer; Lauren Marangell; Mark Kunik; Thomas Ten Have; Martha L Bruce; Ruben Gur; Patricia Marino; Jovier D Evans; Charles F Reynolds; George S Alexopoulos
Journal:  Bipolar Disord       Date:  2010-02       Impact factor: 6.744

5.  Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder.

Authors:  Ariel G Gildengers; Kuo-Hsuan Chung; Shou-Hung Huang; Amy Begley; Howard J Aizenstein; Shang-Ying Tsai
Journal:  Bipolar Disord       Date:  2014-04-10       Impact factor: 6.744

Review 6.  Pharmacologic treatment of geriatric mania.

Authors:  William M McDonald; John Wermager
Journal:  Curr Psychiatry Rep       Date:  2002-02       Impact factor: 5.285

7.  New onset of bipolar disorder in late life.

Authors:  Anthony R Carlino; James L Stinnett; Deborah R Kim
Journal:  Psychosomatics       Date:  2012-05-30       Impact factor: 2.386

Review 8.  A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force.

Authors:  Martha Sajatovic; Sergio A Strejilevich; Ariel G Gildengers; Annemiek Dols; Rayan K Al Jurdi; Brent P Forester; Lars Vedel Kessing; John Beyer; Facundo Manes; Soham Rej; Adriane R Rosa; Sigfried Ntm Schouws; Shang-Ying Tsai; Robert C Young; Kenneth I Shulman
Journal:  Bipolar Disord       Date:  2015-09-19       Impact factor: 6.744

9.  Does age at onset have clinical significance in older adults with bipolar disorder?

Authors:  David Chu; Ariel G Gildengers; Patricia R Houck; Stewart J Anderson; Benoit H Mulsant; Charles F Reynolds; David J Kupfer
Journal:  Int J Geriatr Psychiatry       Date:  2010-12       Impact factor: 3.485

10.  Valproate activates the Notch3/c-FLIP signaling cascade: a strategy to attenuate white matter hyperintensities in bipolar disorder in late life?

Authors:  Peixiong Yuan; Giacomo Salvadore; Xiaoxia Li; Lei Zhang; Jing Du; Guang Chen; Husseini K Manji
Journal:  Bipolar Disord       Date:  2009-05       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.